Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines

Author:

Tian Jun1,He Qin1,Oliveira Christopher1,Qian Yueming1,Egan Susan1,Xu Jianlin1,Qian Nan‐Xin1,Langsdorf Erik2,Warrack Bethanne3,Aranibar Nelly3,Reily Michael3,Borys Michael1,Li Zheng Jian1ORCID

Affiliation:

1. Biologics Process Development Global Product Development and Supply, Bristol‐Myers Squibb Company Devens MA USA

2. Molecular & Cellular Science Bristol‐Myers Squibb Company Princeton NJ USA

3. Drug Development and Preclinical Studies Bristol‐Myers Squibb Company Princeton NJ USA

Publisher

Wiley

Subject

Bioengineering,Environmental Engineering,Biotechnology

Reference56 articles.

1. 2016 FDA drug approvals

2. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type

3. Blockbuster biologics 2016: Sales of recombinant therapeutic antibodies & proteins;RESEARCH‐AND‐MARKETS;Res. Markets,2017

4. Biologics market size worth $399.5 billion By 2025 | growth rate: 3.9%;Grand‐View‐Research;Grand View Res.,2017

5. Monoclonal antibodies (mAbs) market analysis by source (chimeric, murine, humanized, human), by type of production, by indication (cancer, autoimmune, inflammatory, infectious, microbial, viral diseases), by end‐use (hospitals, research, academic institutes, clinics, diagnostic laboratories) and segment forecasts, 2013 ‐ 2024;Grand‐View‐Research;Grand View Res.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3